The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 22, 2022
Filed:
Oct. 26, 2018
Applicant:
Suven Life Sciences Limited, Hyderabad-Telangana, IN;
Inventors:
Ramakrishna Nirogi, Hyderabad, IN;
Abdul Rasheed Mohammed, Hyderabad, IN;
Anil Karbhari Shinde, Hyderabad, IN;
Shankar Reddy Gagginapally, Hyderabad, IN;
Durga Malleshwari Kancharla, Hyderabad, IN;
Santosh Kumar Pandey, Hyderabad, IN;
Renny Abraham, Hyderabad, IN;
Venkateswarlu Jasti, Hyderabad, IN;
Assignee:
Suven Life Sciences Limited, Hyderabad, IN;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61P 25/28 (2006.01); A61K 31/13 (2006.01); A61K 31/27 (2006.01); A61K 31/4155 (2006.01); A61K 31/4184 (2006.01); A61K 31/427 (2006.01); A61K 31/445 (2006.01); A61K 31/4709 (2006.01); A61K 31/473 (2006.01); A61K 31/538 (2006.01); A61K 31/55 (2006.01); C07D 215/48 (2006.01); C07D 235/04 (2006.01); C07D 401/10 (2006.01); C07D 403/10 (2006.01); C07D 405/10 (2006.01); C07D 405/14 (2006.01); C07D 413/10 (2006.01); C07D 417/10 (2006.01); C07D 417/14 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/13 (2013.01); A61K 31/27 (2013.01); A61K 31/4155 (2013.01); A61K 31/4184 (2013.01); A61K 31/427 (2013.01); A61K 31/445 (2013.01); A61K 31/473 (2013.01); A61K 31/4709 (2013.01); A61K 31/538 (2013.01); A61K 31/55 (2013.01); A61P 25/28 (2018.01); C07D 215/48 (2013.01); C07D 235/04 (2013.01); C07D 401/10 (2013.01); C07D 403/10 (2013.01); C07D 405/10 (2013.01); C07D 405/14 (2013.01); C07D 413/10 (2013.01); C07D 417/10 (2013.01); C07D 417/14 (2013.01); C07D 471/04 (2013.01);
Abstract
The present invention relates to compounds of formula (I), or their isotopic forms, stereoisomers, tautomers or pharmaceutically acceptable salt (s) thereof as muscarinic M1 receptor positive allosteric modulators (M1 PAMs). The present invention describes the preparation, pharmaceutical composition and the use of compound formula (I).